The Seattle Times
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
U.S. health advisers evaluate Moderna's first mRNA-based flu vaccine for adults over 50, potentially offering faster manufacturing to combat seasonal virus mutations and save lives.
Read the original at The Seattle TimesMore audio from The Seattle Times
-
7m
Small, unloved and unkempt, these unusual properties are hot in Australia
Desperate buyers in Sydney's expensive market are eyeing dilapidated electrical substations as rare affordable opportunities amidst a severe housing shortage and skyrocketing property prices across Australia.
-
5m
New Yorkers are set to fete the Knicks with a ticker-tape parade
New York City honors the Knicks with a historic ticker-tape parade following their first NBA championship in 53 years, featuring legends, musical performances, and massive crowds in Manhattan.
-
7m
Trump fixates on a new competition with Obama: Their libraries
Donald Trump mocks Barack Obama's new Chicago library as a 'total disaster' while planning his own 47-story Miami skyscraper, highlighting their vastly different approaches to presidential legacies and architecture.
-
4m
Hilton union workers in Pioneer Square strike during FIFA World Cup
Hospitality workers at Seattle's Embassy Suites have launched an indefinite strike during the FIFA World Cup, demanding better pay, staffing levels, and healthcare coverage as contract negotiations stall.
-
10m
Vance, skeptical of foreign wars, becomes the face of Trump's tentative deal to end war with Iran
JD Vance has emerged as the primary defender of a controversial Iran peace deal, tying his political future to the outcome of negotiations amid significant backlash from across the spectrum.